Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

Vmn2r93 Inhibitors

Vmn2r93 inhibitors pertain to a chemical class designed to interact with a specific subset of olfactory receptors, particularly the Vmn2r93 receptor, which is part of a larger family of Vmn2r (vomeronasal type-2 receptors). These receptors are primarily found in the vomeronasal organ (VNO), an olfactory structure involved in the detection of pheromones, which are chemicals responsible for intra-species communication. The Vmn2r93 receptor, like others in its family, is a G protein-coupled receptor (GPCR), meaning it transmits signals into the cell upon activation by a ligand – in this case, specific molecules that might be found in pheromones. The inhibitors of Vmn2r93 are molecules that specifically bind to this receptor and block the interaction with its natural ligands. By doing so, these inhibitors prevent the typical signal transduction pathways normally initiated by the receptor's activation, effectively silencing the receptor's response to its stimulus.

The development and study of Vmn2r93 inhibitors are of interest in various fields of biochemical and physiological research. These inhibitors are useful in dissecting the complex processes of olfactory signaling and the subtle nuances of pheromonal communication. By selectively inhibiting the Vmn2r93 receptor, researchers can observe changes in the molecular pathways and behaviors that are normally influenced by the activation of this receptor. The inhibitors themselves are structurally diverse, with the potential to be small molecules, peptides, or other forms of ligands that exhibit high affinity and specificity to the Vmn2r93 receptor. The design of these inhibitors often involves intricate knowledge of the receptor's structure and the molecular dynamics between the receptor and its natural ligands. Through such targeted inhibition, studies can reveal the receptor's role in the larger context of sensory perception and the mechanisms by which animals, including some mammals, use chemical cues to interact with their environment and each other.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ondansetron

99614-02-5sc-201127
sc-201127A
10 mg
50 mg
$82.00
$333.00
1
(0)

Ondansetron is a serotonin 5-HT3 receptor antagonist. By blocking 5-HT3 receptors, ondansetron could prevent serotonin-mediated activation of pathways that may otherwise enhance Vmn2r93 signaling.

Yohimbine hydrochloride

65-19-0sc-204412
sc-204412A
sc-204412B
1 g
5 g
25 g
$51.00
$171.00
$530.00
2
(1)

Yohimbine is an alpha-2 adrenergic receptor antagonist. By inhibiting these receptors, yohimbine could indirectly reduce sympathetic nervous system activity, potentially diminishing Vmn2r93 signaling.

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

Propranolol, a beta-adrenergic receptor antagonist, may decrease signaling through these pathways, leading to an indirect reduction in Vmn2r93 activity if Vmn2r93 is involved in adrenergic signaling.

Labetalol

36894-69-6sc-484723
50 mg
$180.00
(0)

Labetalol blocks both alpha and beta-adrenergic receptors. By reducing adrenergic signaling, labetalol could indirectly lower Vmn2r93 activity if Vmn2r93 is part of the adrenergic signaling pathway.

Ritanserin

87051-43-2sc-203681
sc-203681A
10 mg
50 mg
$89.00
$312.00
2
(1)

Ritanserin, a 5-HT2A/2C receptor antagonist, may indirectly inhibit Vmn2r93 by altering serotonin signaling pathways that could contribute to the activation of Vmn2r93.

Spiperone

749-02-0sc-471047
250 mg
$130.00
(0)

Spiperone is a potent dopamine and serotonin receptor antagonist, which may lead to a decrease in Vmn2r93 activity by inhibiting neurotransmitter pathways that could influence Vmn2r93 function.

Ketanserin

74050-98-9sc-279249
1 g
$700.00
(0)

Ketanserin is a selective 5-HT2A serotonin receptor antagonist. By influencing serotonin signaling, ketanserin could indirectly inhibit Vmn2r93 if it is functionally related to these serotonin pathways.